The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A Rapamycin-Sensitive Pathway Down-Regulates Insulin Signaling via Phosphorylation and Proteasomal Degradation of Insulin Receptor Substrate-1
Open accessAbstract
Insulin receptor substrate-1 (IRS-1) is a major substrate of the insulin receptor and acts as a docking protein for Src homology 2 domain containing signaling molecules that mediate many of the pleiotropic actions of insulin. Insulin stimulation elicits serine/threonine phosphorylation of IRS-1, which produces a mobility shift on SDS-PAGE, followed by degradation of IRS-1 after prolonged stimulation. We investigated the molecular mechanisms and the functional consequences of these phenomena in 3T3-L1 adipocytes. PI 3-kinase inhibitors or rapamycin, but not the MEK inhibitor, blocked both the insulin-induced electrophoretic mobility shift and degradation of IRS-1. Adenovirus-mediated expression of a membrane-targeted form of the p110 subunit of phosphatidylinositol (PI) 3-kinase (p110CAAX) induced a mobility shift and degradation of IRS-1, both of which were inhibited by rapamycin. Lactacystin, a specific proteasome inhibitor, inhibited insulin-induced degradation of IRS-1 without any effect on its electrophoretic mobility. Inhibition of the mobility shift did not significantly affect tyrosine phosphorylation of IRS-1 or downstream insulin signaling. In contrast, blockade of IRS-1 degradation resulted in sustained activation of Akt, p70 S6 kinase, and mitogen-activated protein (MAP) kinase during prolonged insulin treatment. These results indicate that insulin-induced serine/threonine phosphorylation and degradation of IRS-1 are mediated by a rapamycin-sensitive pathway, which is downstream of PI 3-kinase and independent of ras/MAP kinase. The pathway leads to degradation of IRS-1 by the proteasome, which plays a major role in down-regulation of certain insulin actions during prolonged stimulation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein
Sun, X. J., Rothenberg, P., Kahn, C. R., Backer, J. M., Araki, E., Wilden, P. A., Cahill, D. A., Goldstein, B. J., & White, M. F. (1991) · Nature · doi:10.1038/352073a0 · Cited by 1,574
The Proteasome: Paradigm of a Self-Compartmentalizing Protease
Baumeister, W., Walz, J., Zühl, F., & Seemüller, E. (1998) · Cell · doi:10.1016/s0092-8674(00)80929-0 · Cited by 1,494
The ubiquitin-proteasome pathway: on protein death and cell life
Ciechanover, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.24.7151 · Cited by 1,426
Hara, K., Yonezawa, K., Weng, Q.-P., Kozlowski, M. T., Belham, C., & Avruch, J. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14484 · Cited by 1,367
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Okada, T., Kawano, Y., Sakakibara, T., Hazeki, O., & Ui, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)41901-6 · Cited by 918
Insulin Action and the Insulin Signaling Network*
CHEATHAM, B., & KAHN, C. R. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-2-117 · Cited by 881
Control of p70 S6 kinase by kinase activity of FRAP in vivo
Brown, E. J., Beal, P. A., Keith, C. T., Chen, J., Bum Shin, T., & Schreiber, S. L. (1995) · Nature · doi:10.1038/377441a0 · Cited by 705
The Proteasome, a Novel Protease Regulated by Multiple Mechanisms
DeMartino, G. N., & Slaughter, C. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.32.22123 · Cited by 530
Signaling Mechanisms That Regulate Glucose Transport
Czech, M. P., & Corvera, S. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.1865 · Cited by 515
Peterson, R. T., Desai, B. N., Hardwick, J. S., & Schreiber, S. L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.8.4438 · Cited by 486
TOR signalling and control of cell growth
Thomas, G., & Hall, M. N. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80078-6 · Cited by 462 · cited 2×
“mTOR controls protein synthesis by regulating the translational components, 4E-BP1 and p70 S6 kinase (9).”
BackgroundTumor Necrosis Factor α-induced Phosphorylation of Insulin Receptor Substrate-1 (IRS-1)
Kanety, H., Feinstein, R., Papa, M. Z., Hemi, R., & Karasik, A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.40.23780 · Cited by 434
Lactacystin, Proteasome Function, and Cell Fate
Fenteany, G., & Schreiber, S. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.15.8545 · Cited by 410
Lazar, D. F., Wiese, R. J., Brady, M. J., Mastick, C. C., Waters, S. B., Yamauchi, K., Pessin, J. E., Cuatrecasas, P., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20801 · Cited by 396
Amino acid availability regulates p70 S6 kinase and multiple translation factors
WANG, X., CAMPBELL, L. E., MILLER, C. M., & PROUD, C. G. (1998) · Biochemical Journal · doi:10.1042/bj3340261 · Cited by 338
Expression and function of IRS-1 in insulin signal transmission.
Sun, X. J., Miralpeix, M., Myers, M. G., Glasheen, E. M., Backer, J. M., Kahn, C. R., & White, M. F. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)41723-1 · Cited by 326
Phosphorylation of insulin receptor substrate 1 by glycogen synthase kinase 3 impairs insulin action
Eldar-Finkelman, H., & Krebs, E. G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9660 · Cited by 319
Takayama, S., White, M. F., & Kahn, C. R. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)69090-8 · Cited by 317
Tanti, J. F., Grémeaux, T., van Obberghen, E., & Le Marchand-Brustel, Y. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37568-3 · Cited by 309
De Fea, K., & Roth, R. A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31400 · Cited by 298
Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation
Dennis, P. B., Fumagalli, S., & Thomas, G. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80007-0 · Cited by 275
De Fea, K., & Roth, R. A. (1997) · Biochemistry · doi:10.1021/bi971157f · Cited by 244
Sun, X. J., Goldberg, J. L., Qiao, L. Y., & Mitchell, J. J. (1999) · Diabetes · doi:10.2337/diabetes.48.7.1359 · Cited by 218
Cell cycle regulation by the ubiquitin pathway
Pagano, M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.13.9367342 · Cited by 213
Li, J., DeFea, K., & Roth, R. A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9351 · Cited by 199
Chin, J. E., Dickens, M., Tavare, J. M., & Roth, R. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53258-0 · Cited by 164
Isakoff, S. J., Taha, C., Rose, E., Marcusohn, J., Klip, A., & Skolnik, E. Y. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.22.10247 · Cited by 150
Wiese, R. J., Mastick, C. C., Lazar, D. F., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.7.3442 · Cited by 150
Sutherland, C. D., O’Brien, R. M., & Granner, D. K. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.26.15501 · Cited by 147
Insulin-stimulated GLUT4 Translocation Is Mediated by a Divergent Intracellular Signaling Pathway
Haruta, T., Morris, A. J., Rose, D. W., Nelson, J. G., Mueckler, M., & Olefsky, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.27991 · Cited by 141
Self-citationSun, X., Pons, S., Wang, L.-M., Zhang, Y., Yenush, L., Burks, D. J., Myers, M. G., Glasheen, E. M., Copeland, N. G., Jenkins, N. A., et al. (1997) · Molecular Endocrinology · doi:10.1210/mend.11.2.9885 · Cited by 140
Guilherme, A., & Czech, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.50.33119 · Cited by 122
Upstream Mechanisms of Glycogen Synthase Activation by Insulin and Insulin-like Growth Factor-I
Yamamoto‐Honda, R., Tobe, K., Kaburagi, Y., Ueki, K., Asai, S., Yachi, M., Shirouzu, M., Yodoi, J., Akanuma, Y., Yokoyama, S., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.6.2729 · Cited by 111
Egawa, K., Sharma, P. M., Nakashima, N., Huang, Y., Huver, E., Boss, G. R., & Olefsky, J. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14306 · Cited by 91
Chin, J. E., Liu, F., & Roth, R. A. (1994) · Molecular Endocrinology · doi:10.1210/mend.8.1.7512195 · Cited by 90
Insulin Stimulates the Degradation of IRS-1 in 3T3-L1 Adipocytes
Rice, K. M., Turnbow, M., & Garner, C. W. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1143 · Cited by 88
Staubs, P. A., Nelson, J. G., Reichart, D. R., & Olefsky, J. M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25139 · Cited by 83
Ricort, J., Tanti, J., OBBERGHEN, E. V., & MARCHAND‐BRUSTEL, Y. L. (1995) · Diabetologia · doi:10.1007/bf00422363 · Cited by 78
Sharma, P. M., Egawa, K., Gustafson, T. A., Martin, J. W., & Olefsky, J. M. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.12.7386 · Cited by 74
Morris, A. J., Martin, S. S., Haruta, T., Nelson, J. G., Vollenweider, P., Gustafson, T. A., Mueckler, M. M., Rose, D. W., & Olefsky, J. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8401 · Cited by 68
Self-citationJullien, D., Tanti, J., Heydrick, S. J., Gautier, N., Grémeaux, T., OBBERGHEN, E. V., & MARCHAND‐BRUSTEL, Y. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)82462-0 · Cited by 57
Ricort, J., Tanti, J., OBBERGHEN, E. V., & MARCHAND‐BRUSTEL, Y. L. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.32.19814 · Cited by 49
Smith, L. K., Rice, K. M., & Garner, C. W. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(96)03875-0 · Cited by 46
Regulation of System A Amino Acid Transport in 3T3-L1 Adipocytes by Insulin
Su, T., Wang, M., Syu, L.-J., Saltiel, A. R., & Oxender, D. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3173 · Cited by 32
Wortmannin and LY294002 inhibit the insulin-induced down-regulation of IRS-1 in 3T3-L1 adipocytes
Smith, L. K., Vlahos, C. J., Reddy, K. K., Falck, J. R., & Garner, C. W. (1995) · Molecular and Cellular Endocrinology · doi:10.1016/0303-7207(95)03622-e · Cited by 21
Research works printed but not linked: 1
- Smith, 1993, The insulin receptor substrate (IRS-1) is a PEST protein that is susceptible to calpain degradation in vitro., Biochem Biophys Res Commun, 196, 767, 10.1006/bbrc.1993.2315 · doi:10.1006/bbrc.1993.2315
Cited by
Molecular mechanisms of mTOR-mediated translational control
Ma, X. M., & Blenis, J. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2672 · Cited by 2,558
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Growing roles for the mTOR pathway
Sarbassov, D. D., Ali, S. M., & Sabatini, D. M. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.09.009 · Cited by 1,560
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Metadata
- Authors
- Haruta, T.
- Venue
- Molecular Endocrinology
- Publisher
- The Endocrine Society
- Published
- 2000-06-01
- Volume
- 14
- Issue
- 6
- Pages
- 783-794
- ISSN
- 0888-8809 (ISSN-L)
- OpenAlex
- W2030977583
- Cited by
- 419
- References
- 47
- FWCI
- 4.96
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.